{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:32Z","timestamp":1741238672576,"version":"3.38.0"},"reference-count":10,"publisher":"JLE","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1684\/ejd.2018.3372","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:13:54Z","timestamp":1696864434000},"page":"693-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spontaneous remission of methotrexateassociated lymphoproliferative disorder with Epstein-Barr virus type II latency"],"prefix":"10.1684","volume":"28","author":[{"given":"Yasushi","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Minakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Takiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"3372_CR1","doi-asserted-by":"publisher","first-page":"23922","DOI":"10.3390\/ijms141223922","volume":"14","author":"X Liu","year":"2013","unstructured":"Liu X, Tang J, Wang M, Ma Q, Wang Y. Visual detection and evaluation of latent and lytic gene expression during Epstein\u2013Barr virus infection using one\u2013step reverse transcription loop\u2013mediated isothermal amplification. Int J Mol Sci 2013; 14: 23922\u201340.","journal-title":"Int J Mol Sci"},{"key":"3372_CR2","first-page":"1741","volume":"18","author":"MH Ellman","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18: 1741\u20133.","journal-title":"J Rheumatol"},{"key":"3372_CR3","first-page":"350","volume-title":"In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Swerdlow SH, Campo E, Harris NL, et al. Lyon: IARC Press","author":"P Gaulard","year":"2008","unstructured":"Gaulard P, Swerdlow SH, Harris L, Jaffe ES, Sundstrom C. Other iatrogenic immunodeficiency\u2013associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Swerdlow SH, Campo E, Harris NL, et al. Lyon: IARC Press, 2008: 350\u20131."},{"key":"3372_CR4","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals\u2013Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3\u2013year prospective study in France. Blood 2002; 99: 3909\u201315.","journal-title":"Blood"},{"key":"3372_CR5","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007; 34: 322\u201331.","journal-title":"J Rheumatol"},{"key":"3372_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.prp.2006.05.007","volume":"202","author":"M Kojima","year":"2006","unstructured":"Kojima M, Itoh H, Hirabayashi K, et al. Methtrexate\u2013associated lymphoproliferative disorders. a clinicopathological study of 13 Japanese cases. Pathol Res Pract 2006; 202: 679\u201385.","journal-title":"Pathol Res Pract"},{"key":"3372_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein\u2013Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 2013; 91: 20\u20138.","journal-title":"Eur J Haematol"},{"key":"3372_CR8","first-page":"77","volume":"39","author":"G Terroso","year":"2014","unstructured":"Terroso G, Aleixo J, Bernardes M, Mariz E, Fonseca E, Costa L. Nasal type extranodal NK\/T cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate. Acta Reumatol Port 2014; 39: 77\u201381.","journal-title":"Acta Reumatol Port"},{"key":"3372_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00428-013-1389-1","volume":"462","author":"S Kondo","year":"2013","unstructured":"Kondo S, Tanimoto K, Yamada K, et al. Mature T\/NK\u2013cell lymphoproliferative disease and Epstein\u2013Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch 2013; 462: 399\u2013407.","journal-title":"Virchows Arch"},{"key":"3372_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3899\/jrheum.130270","volume":"41","author":"N Yamakawa","year":"2014","unstructured":"Yamakawa N, Fujimoto M, Kawabata D, et al. A clinical, pathological, and genetic characterization of methotrexate\u2013associated lymphoproliferative disorders. J Rheumatol 2014; 41: 293\u20139.","journal-title":"J Rheumatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3372\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:22:32Z","timestamp":1741191752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3372","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"11 Januar 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}